USF

State Law Names TGH Behavioral Health Hospital One of First Behavioral Health Teaching Hospitals in Florida

Retrieved on: 
月曜日, 5月 13, 2024

TAMPA, Fla., May 13, 2024 /PRNewswire/ -- Tampa General Hospital (TGH) and University of South Florida (USF) celebrated today a new state law that names the TGH Behavioral Health Hospital one of the first four behavioral health teaching hospitals in the state of Florida and creates the Florida Center for Behavioral Health Workforce within the University of South Florida's Louis de la Parte Florida Mental Health Institute (FMHI).

Key Points: 
  • The TGH Behavioral Health Hospital is a state-of-the-art facility that will serve as one of the first and only freestanding academic medical behavioral health hospitals in Florida.
  • "Now, with Senate Bill 330 signed into law, the TGH Behavioral Health Hospital is one of the state's first behavioral health teaching hospitals, where patients needing behavioral health services will have access to academic-based, world-class care.
  • The bill, signed by the Governor into law, names Tampa General, in partnership with USF Health, as the first of just four behavioral health teaching hospitals in the state.
  • In collaboration with the state, universities and private organizations, behavioral health teaching hospitals will also provide leading-edge education and training to strengthen Florida's behavioral health workforce.

Helping Students Launch Careers: Aramark Collegiate Hospitality and USF’s School of Hospitality and Tourism Partner for Post-Grad Success

Retrieved on: 
木曜日, 5月 9, 2024

Aramark Collegiate Hospitality and University of South Florida’s School of Hospitality and Tourism Management know that a strong educational foundation coupled with hands-on experience leads to post-graduation success.

Key Points: 
  • Aramark Collegiate Hospitality and University of South Florida’s School of Hospitality and Tourism Management know that a strong educational foundation coupled with hands-on experience leads to post-graduation success.
  • View the full release here: https://www.businesswire.com/news/home/20240509753261/en/
    Aramark Collegiate Hospitality and University of South Florida’s School of Hospitality and Tourism Management know that a strong educational foundation coupled with hands-on experience leads to post-graduation success.
  • The first year of their partnership resulted in 100% job placement for the inaugural Fall 2022 and Spring 2023 classes.
  • “The partnership between USF's School of Hospitality and Tourism and Aramark exemplifies the power of collaboration in shaping the future of the hospitality industry,” said Cihan Cobanoglu, Dean of USF’s School of Hospitality and Tourism Management.

Consolidated Communications Announces First Quarter 2024 Financial Results

Retrieved on: 
火曜日, 5月 7, 2024

Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) (the “Company” or “Consolidated”), a top 10 fiber provider in the U.S., today reported results for first quarter 2024.

Key Points: 
  • Consolidated Communications Holdings, Inc. (Nasdaq: CNSL) (the “Company” or “Consolidated”), a top 10 fiber provider in the U.S., today reported results for first quarter 2024.
  • 31, 2024, the Company had 73% of its total outstanding debt at a fixed rate through September 2026.
  • Net loss in the first quarter of 2024 was ($47.2 million) compared to net loss of ($47.7 million) in the first quarter of 2023.
  • Net loss per share was ($0.41) in the first quarter of 2024 as compared to net loss per share of ($0.42) in the first quarter of 2023.

TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

Retrieved on: 
木曜日, 4月 18, 2024

NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 American Academy of Neurology (AAN) annual meeting, being held in Denver, Colorado.

Key Points: 
  • NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced two additional data presentations from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 American Academy of Neurology (AAN) annual meeting, being held in Denver, Colorado.
  • Links to the data presented yesterday are included below.
  • Michael S. Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated “The data presented this week during the AAN annual meeting emphasizes our commitment to research and the multiple sclerosis community.
  • We look forward to continuing to evaluate date from the ULTIMATE Phase 3 trials and presenting additional exploratory data throughout the year.”
    Link to Poster Presentation: Ublituximab Significantly Reduces Radiological Disease Activity at 12 Weeks: Post-hoc analysis of Participants with Highly Active Disease in the ULTIMATE I & II Phase 3 Studies
    Lead Author: Derrick Robertson, MD - University of South Florida (USF) Morsani College of Medicine in Tampa, Florida
    Lead Author: Derrick Robertson, MD - University of South Florida (USF) Morsani College of Medicine in Tampa, Florida
    All data presented at AAN is also available on the Publications page, located within the Pipeline section, of the Company’s website at www.tgtherapeutics.com/publications.cfm .

TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting

Retrieved on: 
月曜日, 4月 15, 2024

NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 American Academy of Neurology (AAN) annual meeting, being held in Denver, Colorado.

Key Points: 
  • NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the 2024 American Academy of Neurology (AAN) annual meeting, being held in Denver, Colorado.
  • A link to the data presented yesterday is included below.
  • Two additional presentations will be shared on Wednesday April 17, 2024.
  • Michael S. Weiss, Chief Executive Officer and Chairman of TG Therapeutics stated “The ULTIMATE I & II Phase 3 trials demonstrated robust clinical activity for BRIUMVI compared to teriflunomide and these post-hoc analyses provide interesting new insights and support BRIUMVI’s utility as an important treatment option for patients with relapsing forms of multiple sclerosis.

Tampa General Hospital to Establish Dr. Jagadamba and Krishna Chivukula Men's Center with $6.5 Million Gift from Family

Retrieved on: 
水曜日, 4月 10, 2024

TAMPA, Fla., April 10, 2024 /PRNewswire/ -- Tampa General Hospital (TGH) revealed plans this week for a new center focused on men's health made possible with the generous contribution of Dr. Jagadamba and Krishna Chivukula to the TGH Foundation.

Key Points: 
  • TAMPA, Fla., April 10, 2024 /PRNewswire/ -- Tampa General Hospital (TGH) revealed plans this week for a new center focused on men's health made possible with the generous contribution of Dr. Jagadamba and Krishna Chivukula to the TGH Foundation.
  • The Dr. Jagadamba and Krishna Chivukula Men's Health Center will provide seamless, coordinated, comprehensive primary and preventive care for male patients, just as the Muma Center focuses on women's health.
  • Construction on the Dr. Jagadamba and Krishna Chivukula Men's Health Center is expected to begin in the next couple of months, with plans to open in 2025.
  • "We are extremely honored to partner with the Chivukula family as they make their first gift to Tampa General.

WatchGuard Threat Lab Analysis Shows Surge in Evasive Malware Supercharging an Already Powerful Threat Wave

Retrieved on: 
水曜日, 3月 27, 2024

The average malware detections per Firebox rose 80% from the previous quarter, illustrating a substantial volume of malware threats arriving at the network perimeter.

Key Points: 
  • The average malware detections per Firebox rose 80% from the previous quarter, illustrating a substantial volume of malware threats arriving at the network perimeter.
  • Zero-day malware detections jumped to 60% of all malware detections, up from 22% the previous quarter.
  • However, zero-day malware detections with TLS fell to 61%, which was a 10% decrease from Q3, showing the unpredictability of malware in the wild.
  • Both variants redirect users to malicious links, and both malware loaders attempt to load DarkGate malware on the victim’s computer.

CES Power Announces Partnership Extension with James Roe for 2024 INDY NXT by Firestone Season

Retrieved on: 
火曜日, 3月 26, 2024

MEMPHIS, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- CES Power, the leading global provider of cutting-edge power generation, distribution, and temperature control equipment, and Irish race car driver James Roe today announced the extension of their partnership for the 2024 INDY NXT™ by Firestone championship season.

Key Points: 
  • MEMPHIS, Tenn., March 26, 2024 (GLOBE NEWSWIRE) -- CES Power, the leading global provider of cutting-edge power generation, distribution, and temperature control equipment, and Irish race car driver James Roe today announced the extension of their partnership for the 2024 INDY NXT™ by Firestone championship season.
  • 29 Topcon Dallara entry of Andretti Global this season in the INDY NXT by Firestone championship, the official development series for the NTT INDYCAR SERIES.
  • “Our renewed partnership with James Roe and the launch of CES Global and CES Technologies represents our commitment to innovation, sustainability, and global growth.
  • The 2024 INDY NXT by Firestone season kicked off on March 10 with Roe featuring the CES Power logo on the sleeves of his race suit and on the front wing of his Andretti Global machine.

California Supreme Court Justice Martin J. Jenkins ’77 to Address Santa Clara University Class of 2024

Retrieved on: 
月曜日, 4月 8, 2024

Martin J. Jenkins ’77, California Supreme Court Associate Justice and former Judicial Appointments Secretary to California Gov.

Key Points: 
  • Martin J. Jenkins ’77, California Supreme Court Associate Justice and former Judicial Appointments Secretary to California Gov.
  • Gavin Newsom ’89, will be the keynote speaker at Santa Clara University’s 173rd commencement ceremony on June 15.
  • Justice Jenkins was confirmed as an Associate Justice of the California Supreme Court on November 10, 2020.
  • “I look forward to celebrating commencement with Santa Clara University’s Class of 2024,” said Jenkins.

University of South Florida plans to launch college focused on artificial intelligence, cybersecurity and computing

Retrieved on: 
木曜日, 3月 21, 2024

TAMPA, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- The University of South Florida announced today its intention to create a college focused on the rapidly evolving fields of artificial intelligence (AI), cybersecurity and computing, with the goal of positioning the Tampa Bay region and state of Florida as a national leader.

Key Points: 
  • TAMPA, Fla., March 21, 2024 (GLOBE NEWSWIRE) -- The University of South Florida announced today its intention to create a college focused on the rapidly evolving fields of artificial intelligence (AI), cybersecurity and computing, with the goal of positioning the Tampa Bay region and state of Florida as a national leader.
  • USF is the first university in Florida and among the first in the nation to announce plans to create a college dedicated to AI and cybersecurity.
  • The creation of a new college would leverage USF's existing strengths and partnerships in AI, cybersecurity and computing, as well as its location in the Tampa Bay region, a hub for technology and defense industries.
  • At USF, there are approximately 200 faculty members currently engaged in research in related disciplines, which are seeing significant growth in funding awards.